speb/financial-data huggingface dataset:
Financial ratios for DHT — quarterly report dated 2025-03-31
Total revenue: 118574000
Gross profit: 34648000
Operating income: 29100000
Net income: 44122000
Capital expenditures: 16675000
Operating cash flow: 59212000
Depreciation & amortization: 27270000
Net tangible assets: 1055648000
Owner earnings: 54717000
Return on net tangible assets (%): 5.183261844857377
Capex to operating income (%): 57.302405498281786
Buffett classification: The Good
Stock price: 9.76
P/E ratio: 8.905797431666743
Shares outstanding: 161041637
Book value: 1061457000
P/B ratio: 1.4807631181668215
Market cap (USD): 1571766377.12
Debt to equity: 0.34299269777296676
Current ratio: 1.5939793195463643
Quick ratio: 1.2879141649988881
Effective tax rate (%): 0.19032513877874702
Interest coverage ratio: 5.699177438307873
COGS to revenue (%): 70.77942887985562
SG&A to revenue (%): 4.6789346737058715
Free cash flow (dilution-adjusted): 31548000
Buyback yield (%): 0
Retained earnings: -169485000
Inventory turnover: 2.540671449762359
Receivables turnover: 2.347070467141726
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1553799320055402
FCF margin (%): 26.60616998667499
Rule of 40 score: 26.60616998667499
Financial ratios for DHT — quarterly report dated 2025-06-30
Total revenue: 128316000
Gross profit: 47441000
Operating income: 42854000
Net income: 56099000
Capital expenditures: 11064000
Operating cash flow: 83577000
Depreciation & amortization: 26139000
Net tangible assets: 1087521000
Owner earnings: 71174000
Return on net tangible assets (%): 6.544609253522461
Capex to operating income (%): 25.817893312176228
Buffett classification: The Good
Stock price: 10.18
P/E ratio: 16.3578877147504
Shares outstanding: 161041637
Book value: 1088940000
P/B ratio: 1.5055043112200857
Market cap (USD): 1639403864.6599998
Debt to equity: 0.27807317207559645
Current ratio: 2.3259525210437206
Quick ratio: 1.9575643319444278
Effective tax rate (%): 0.05172936622607517
Interest coverage ratio: 10.237458193979933
COGS to revenue (%): 63.02799339131519
SG&A to revenue (%): 3.574768540166464
Free cash flow (dilution-adjusted): 42491000
Buyback yield (%): 0
Retained earnings: -139326000
Inventory turnover: 2.6361680628442907
Receivables turnover: 3.2041351412090795
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1811426696537666
FCF margin (%): 33.11434271641885
Revenue growth (%): 8.215966400728659
Rule of 40 score: 41.33030911714751
Financial ratios for DHT — quarterly report dated 2025-09-30
Total revenue: 107348000
Gross profit: 34896000
Operating income: 31734000
Net income: 44805000
Capital expenditures: 11508000
Operating cash flow: 60894000
Depreciation & amortization: 25969000
Net tangible assets: 1094249000
Owner earnings: 59266000
Return on net tangible assets (%): 5.416134718880254
Capex to operating income (%): 36.26394403478918
Buffett classification: The Good
Stock price: 11.25
P/E ratio: 12.492369756112698
Shares outstanding: 161041637
Book value: 1095669000
P/B ratio: 1.653527129315514
Market cap (USD): 1811718416.25
Debt to equity: 0.24508040293190736
Current ratio: 2.4109800825644316
Quick ratio: 2.024506175885265
Effective tax rate (%): 0.20713617533074968
Interest coverage ratio: 12.271461716937354
COGS to revenue (%): 67.49264075716361
SG&A to revenue (%): 3.8491634683459406
Free cash flow (dilution-adjusted): 21651000
Buyback yield (%): 0
Retained earnings: -133115000
Inventory turnover: 3.083326240531109
Receivables turnover: 3.161664654080641
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3730897278282796
FCF margin (%): 20.168983120318963
Revenue growth (%): -16.340908382430875
Rule of 40 score: 3.8280747378880875
Financial ratios for DHT — annual report dated 2025-12-31
Total revenue: 498400000
Gross profit: 190948000
Operating income: 172028000
Net income: 211092000
Capital expenditures: 166421000
Operating cash flow: 276650000
Depreciation & amortization: 106370000
Net tangible assets: 1131830000
Owner earnings: 151041000
Return on net tangible assets (%): 13.344848608006501
Capex to operating income (%): 96.74064687143952
Buffett classification: The Gruesome
Stock price: 11.49
P/E ratio: 8.765696516826786
Shares outstanding: 161041637
Book value: 1133257000
P/B ratio: 1.632787981128729
Market cap (USD): 1850368409.13
Debt to equity: 0.37920612888338656
Current ratio: 2.7959716274089934
Quick ratio: 2.4656450749464667
Effective tax rate (%): 0.19538642040723642
Interest coverage ratio: 12.141153221822288
COGS to revenue (%): 61.68780096308186
SG&A to revenue (%): 3.990770465489567
Free cash flow (dilution-adjusted): -37672000
Buyback yield (%): 0
Retained earnings: -96216000
Inventory turnover: 12.456527023741998
Receivables turnover: 9.344182384041396
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.256689933249532
FCF margin (%): -7.558587479935795
Revenue growth (%): -12.832540186402646
Rule of 40 score: -20.39112766633844
Financial ratios for DHT — quarterly report dated 2025-12-31
Total revenue: 144163000
Gross profit: 73964000
Operating income: 68341000
Net income: 66075000
Capital expenditures: 205670000
Operating cash flow: 72967000
Depreciation & amortization: 26991000
Net tangible assets: 1131830000
Owner earnings: -112604000
Return on net tangible assets (%): -9.948843907653975
Capex to operating income (%): 300.9467230505846
Buffett classification: The Gruesome
Stock price: 11.49
P/E ratio: 8.765322803444796
Shares outstanding: 161041637
Book value: 1133257000
P/B ratio: 1.632787981128729
Market cap (USD): 1850368409.13
Debt to equity: 0.37920612888338656
Current ratio: 2.7959716274089934
Quick ratio: 2.4656450749464667
Effective tax rate (%): 0.31230198243867113
Interest coverage ratio: 29.843231441048037
COGS to revenue (%): 48.69418644173609
SG&A to revenue (%): 3.9004460229046285
Free cash flow (dilution-adjusted): -133364000
Buyback yield (%): 0
Retained earnings: -96216000
Inventory turnover: 2.8441374280852445
Receivables turnover: 2.7028197532715885
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.471908333109763
FCF margin (%): -92.50917364372273
Revenue growth (%): 34.295003167269066
Rule of 40 score: -58.21417047645367
Financial ratios for DRR.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.4586466165413534
Shares outstanding: 529456506
Market cap (USD): 1301746447.0827067
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRR.AX — annual report dated 2022-06-30
Total revenue: 182865517.24137932
Gross profit: 182865517.24137932
Operating income: 176821379.31034485
Net income: 123077241.37931035
Capital expenditures: 6896.551724137931
Depreciation & amortization: 271034.4827586207
Net tangible assets: 75879310.34482759
Owner earnings: 123341379.31034485
Return on net tangible assets (%): 162.5494205862304
Capex to operating income (%): 0.003900292911997691
Buffett classification: The Great
Stock price: 2.2482758620689656
P/E ratio: 9.67168478197039
Shares outstanding: 529456506
Book value: 81810344.8275862
P/B ratio: 14.550290491549
Market cap (USD): 1190364282.4551725
Debt to equity: 0.0020906217070600632
Current ratio: 211.5820895522388
Quick ratio: 211.5820895522388
Effective tax rate (%): 30.16060610804126
Interest coverage ratio: 239.17070895522392
COGS to revenue (%): 0
SG&A to revenue (%): 1.3267711338650976
Free cash flow (dilution-adjusted): 88141379.31034483
Buyback yield (%): 0
Retained earnings: 80528275.86206897
Receivables turnover: 2.341944886062533
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 169.10104207888142
FCF margin (%): 48.20010936999113
Rule of 40 score: 48.20010936999113
Financial ratios for DRR.AX — annual report dated 2023-06-30
Total revenue: 151830463.57615894
Gross profit: 151830463.57615894
Operating income: 144996688.74172184
Net income: 100965562.91390729
Capital expenditures: 58940.39735099338
Depreciation & amortization: 262251.65562913904
Net tangible assets: 55529139.07284768
Owner earnings: 101168874.17218544
Return on net tangible assets (%): 182.190604539112
Capex to operating income (%): 0.04064947817945147
Buffett classification: The Great
Stock price: 2.52317880794702
P/E ratio: 13.231377086541867
Shares outstanding: 529456506
Book value: 61018543.04635762
P/B ratio: 21.893564955393
Market cap (USD): 1335913435.6688743
Debt to equity: 0.002018711063839024
Current ratio: 107.20351239669421
Quick ratio: 107.20351239669421
Effective tax rate (%): 29.972624384507974
Interest coverage ratio: 87.75350701402806
COGS to revenue (%): 0
SG&A to revenue (%): 1.8319491939423547
Free cash flow (dilution-adjusted): 120683443.70860927
Buyback yield (%): 0
Retained earnings: 59007284.76821192
Receivables turnover: 3.1361348216239877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 194.6091284831785
FCF margin (%): 79.4856584548817
Revenue growth (%): -16.971517721547606
Rule of 40 score: 62.514140733334095
Financial ratios for DRR.AX — annual report dated 2024-06-30
Total revenue: 160339333.33333334
Gross profit: 160339333.33333334
Operating income: 151628666.66666666
Net income: 103257333.33333333
Capital expenditures: 58666.666666666664
Depreciation & amortization: 308000
Net tangible assets: 48246666.666666664
Owner earnings: 103506666.66666666
Return on net tangible assets (%): 214.5364101146884
Capex to operating income (%): 0.038691012693290186
Buffett classification: The Great
Stock price: 2.36
P/E ratio: 12.101003520266518
Shares outstanding: 529456506
Book value: 53567999.99999999
P/B ratio: 23.325816796594985
Market cap (USD): 1249517354.1599998
Debt to equity: 0.006185284747112704
Current ratio: 12.855391473948176
Quick ratio: 12.855391473948176
Effective tax rate (%): 30.101810567359244
Interest coverage ratio: 65.678024833959
COGS to revenue (%): 0
SG&A to revenue (%): 2.015724983264659
Free cash flow (dilution-adjusted): 113396666.66666667
Buyback yield (%): 0
Retained earnings: 50785333.333333336
Receivables turnover: 4.100051142175248
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 241.66241659229038
FCF margin (%): 70.72292512962093
Revenue growth (%): 5.604191383441512
Rule of 40 score: 76.32711651306245
Financial ratios for DRREDDY.NS — annual report dated 2022-03-31
Operating income: 388711591.7183173
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.95951470394303
Shares outstanding: 833000073
Market cap (USD): 9129276548.429117
Buyback yield (%): 0
Capitalized R&D asset: 230542001.846235
ROCI (R&D-adjusted, %): 235.274377454906
Rule of 40 score: 0
Financial ratios for DRREDDY.NS — annual report dated 2023-03-31
Total revenue: 2994872107.1863585
Gross profit: 1697235079.171742
Operating income: 719293544.4579781
Net income: 548928136.4190012
Capital expenditures: 136918392.2046285
Operating cash flow: 717113276.4920828
Depreciation & amortization: 153909866.01705238
Net tangible assets: 2386077953.714982
Owner earnings: 565919610.2314252
Return on net tangible assets (%): 23.717565863693675
Capex to operating income (%): 19.03512039827954
Buffett classification: The Great
Stock price: 10.968574908647991
P/E ratio: 16.644844913971642
Shares outstanding: 833000073
Book value: 2813532277.7101097
P/B ratio: 3.2474565058290583
Market cap (USD): 9136823699.609745
Debt to equity: 0.05832261863016308
Current ratio: 2.379323198788514
Quick ratio: 1.8123711340206188
Effective tax rate (%): 25.344973246972685
Interest coverage ratio: 41.35434173669467
COGS to revenue (%): 43.328629122454544
R&D to revenue (%): 7.88233236673323
SG&A to revenue (%): 27.66645382484881
Free cash flow (dilution-adjusted): 482484774.66504264
Buyback yield (%): 0
Retained earnings: 2625980511.5712547
Inventory turnover: 2.188945962605301
Receivables turnover: 2.955169885701237
Capitalized R&D asset: 390528914.68399334
ROCI (R&D-adjusted, %): 24.495524213374882
FCF margin (%): 16.110363227441137
Rule of 40 score: 16.110363227441137
Financial ratios for DRREDDY.NS — annual report dated 2024-03-31
Total revenue: 3347691569.7325816
Gross profit: 1961949874.0856218
Operating income: 783163448.8547788
Net income: 667753927.329416
Capital expenditures: 183942918.81520566
Operating cash flow: 544825518.6473198
Depreciation & amortization: 177970979.73378104
Net tangible assets: 2870200263.820602
Owner earnings: 661781988.2479914
Return on net tangible assets (%): 23.056996983446563
Capex to operating income (%): 23.4871684939058
Buffett classification: The Great
Stock price: 14.502759117082535
P/E ratio: 18.091693524808687
Shares outstanding: 833000073
Book value: 3364312267.657993
P/B ratio: 3.590867446927275
Market cap (USD): 12080799403.231167
Debt to equity: 0.07135982890750311
Current ratio: 2.582794489738544
Quick ratio: 1.9210633180270515
Effective tax rate (%): 22.521218867399472
Interest coverage ratio: 38.16949152542373
COGS to revenue (%): 41.393947643678985
R&D to revenue (%): 8.193391698069952
SG&A to revenue (%): 27.6543537132295
Free cash flow (dilution-adjusted): 210948554.9826118
Buyback yield (%): 0
Retained earnings: 3180920973.7378583
Inventory turnover: 1.8183062688821752
Receivables turnover: 2.9281503702615956
Capitalized R&D asset: 508532411.9702152
ROCI (R&D-adjusted, %): 20.24242510162659
Rosenberg metric: 1.1213603355053678
FCF margin (%): 6.301313922998668
Revenue growth (%): 11.780785620181032
Rule of 40 score: 18.0820995431797
Financial ratios for DRREDDY.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.926301958910654
Shares outstanding: 833000073
Market cap (USD): 13266610694.392618
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRREDDY.NS — quarterly report dated 2024-12-31
Operating income: 218207250.2622683
Capital expenditures: 0
Depreciation & amortization: 31856859.773866415
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.981466371371953
Shares outstanding: 833000073
Market cap (USD): 13312562653.999882
Buyback yield (%): 0
Capitalized R&D asset: 77608112.8336636
ROCI (R&D-adjusted, %): 347.8321818363873
Rule of 40 score: 0
Financial ratios for DRREDDY.NS — annual report dated 2025-03-31
Total revenue: 3805646481.1783957
Gross profit: 2226186579.3780684
Operating income: 841875146.1304653
Net income: 669219078.7935468
Capital expenditures: 315548281.5057283
Operating cash flow: 542763619.359364
Depreciation & amortization: 199415478.13888237
Net tangible assets: 2627718026.6541967
Owner earnings: 553086275.4267008
Return on net tangible assets (%): 21.04815927038149
Capex to operating income (%): 37.48160079984447
Buffett classification: The Good
Stock price: 13.184969074571129
P/E ratio: 16.41178584062568
Shares outstanding: 833000073
Book value: 3941617956.511574
P/B ratio: 2.7864395592871665
Market cap (USD): 10983080201.620493
Debt to equity: 0.13870319071317985
Current ratio: 1.9181544880053993
Quick ratio: 1.3729906742744955
Effective tax rate (%): 25.446707647426546
Interest coverage ratio: 25.45563803464122
COGS to revenue (%): 41.5030641866466
R&D to revenue (%): 8.410769963291196
SG&A to revenue (%): 28.83560907429309
Free cash flow (dilution-adjusted): 135679214.40261865
Buyback yield (%): 0.1478457500424267
Retained earnings: 3691758241.7582417
Inventory turnover: 1.9006400787789268
Receivables turnover: 2.965015665986593
Capitalized R&D asset: 581759830.0969924
ROCI (R&D-adjusted, %): 18.361448411042545
Rosenberg metric: 0.9633497509875015
FCF margin (%): 3.5652080421460055
Revenue growth (%): 13.679722337216274
Rule of 40 score: 17.24493037936228
Financial ratios for DRREDDY.NS — quarterly report dated 2025-03-31
Total revenue: 994388590.1332709
Gross profit: 661211129.2962357
Operating income: 189385083.00210425
Net income: 186263736.26373625
Capital expenditures: 89689034.36988543
Operating cash flow: 257142857.14285713
Depreciation & amortization: 53238251.11059153
Net tangible assets: 2627718026.6541967
Owner earnings: 149812953.00444233
Return on net tangible assets (%): 5.701256812367923
Capex to operating income (%): 47.35802469135803
Buffett classification: The Good
Stock price: 13.184969074571129
P/E ratio: 14.741302335508331
Shares outstanding: 833000073
Book value: 3941617956.511574
P/B ratio: 2.7864395592871665
Market cap (USD): 10983080201.620493
Debt to equity: 0.13870319071317985
Current ratio: 1.9181544880053993
Quick ratio: 1.3729906742744955
Effective tax rate (%): 20.870736086175942
Interest coverage ratio: 24.69512195121951
COGS to revenue (%): 33.50576063954856
R&D to revenue (%): 8.532800376205032
SG&A to revenue (%): 16.466023983070773
Free cash flow (dilution-adjusted): 124351180.73415945
Buyback yield (%): 0
Retained earnings: 3691758241.7582417
Inventory turnover: 0.40092846592108045
Receivables turnover: 0.7747376858058875
Capitalized R&D asset: 136846628.95838624
ROCI (R&D-adjusted, %): 5.029563665055864
FCF margin (%): 12.505290383258878
Rule of 40 score: 12.505290383258878
Financial ratios for DRREDDY.NS — quarterly report dated 2025-06-30
Total revenue: 999906388.9538966
Gross profit: 569003042.3589984
Operating income: 197074654.80926752
Net income: 165902176.45682192
Capital expenditures: 79908729.23004915
Operating cash flow: 171179499.18090335
Depreciation & amortization: 55757079.33536158
Net tangible assets: 2837432717.060613
Owner earnings: 141750526.56213433
Return on net tangible assets (%): 4.995731729948409
Capex to operating income (%): 40.54744092150575
Buffett classification: The Good
Stock price: 14.827755675169671
P/E ratio: 35.07301846571212
Shares outstanding: 833000073
Book value: 4139421951.7903113
P/B ratio: 2.983875938160987
Market cap (USD): 12351521559.8425
Debt to equity: 0.13750759706576585
Current ratio: 1.892812309332286
Quick ratio: 1.3626245695731147
Effective tax rate (%): 25.993594791830738
Interest coverage ratio: 20.291566265060244
COGS to revenue (%): 43.0943687684314
R&D to revenue (%): 7.307026166736881
SG&A to revenue (%): 27.127510181154328
Free cash flow (dilution-adjusted): 51135033.93400422
Buyback yield (%): 0
Retained earnings: 3861116311.724784
Inventory turnover: 0.4871031746031746
Receivables turnover: 0.7402094540162678
Capitalized R&D asset: 155523058.2699313
ROCI (R&D-adjusted, %): 4.196629103359602
Rosenberg metric: -1.0867290929472688
FCF margin (%): 5.113982118616299
Revenue growth (%): 0.5548936175832699
Rule of 40 score: 5.668875736199569
Financial ratios for DRREDDY.NS — quarterly report dated 2025-09-30
Total revenue: 992683201.8038331
Gross profit: 542728297.6324689
Operating income: 201431792.55918828
Net income: 162029312.2886133
Capital expenditures: 57643742.95377678
Operating cash flow: 175569334.83652762
Depreciation & amortization: 56944757.60992108
Net tangible assets: 2764926719.2784667
Owner earnings: 161330326.94475758
Return on net tangible assets (%): 5.834886176905919
Capex to operating income (%): 28.61700341411541
Buffett classification: The Good
Stock price: 13.70901916572717
P/E ratio: 22.208712586946806
Shares outstanding: 833000073
Book value: 4082096956.031567
P/B ratio: 2.797487195627703
Market cap (USD): 11419613965.809132
Debt to equity: 0.16167332261752862
Current ratio: 1.8520012986410648
Quick ratio: 1.3496326038415922
Effective tax rate (%): 22.245231607629425
Interest coverage ratio: 19.699007717750828
COGS to revenue (%): 45.327139952981796
R&D to revenue (%): 7.043645160191252
SG&A to revenue (%): 30.02350910267913
Free cash flow (dilution-adjusted): 60180383.3145434
Buyback yield (%): 0
Retained earnings: 3807023675.310034
Inventory turnover: 0.5263845108874851
Receivables turnover: 0.7286516993404557
Capitalized R&D asset: 146873808.50273418
ROCI (R&D-adjusted, %): 4.289154230898991
Rosenberg metric: -0.3596155804499054
FCF margin (%): 6.0623956570623845
Revenue growth (%): -0.7223863383471749
Rule of 40 score: 5.340009318715209
Financial ratios for DRREDDY.NS — quarterly report dated 2025-12-31
Total revenue: 972128773.5323606
Gross profit: 521399131.11284393
Operating income: 159630165.979726
Net income: 134766625.82154396
Capital expenditures: 74568341.31669824
Operating cash flow: 121510526.90208311
Depreciation & amortization: 58070624.93037763
Net tangible assets: 2869989974.3789687
Owner earnings: 118268909.43522336
Return on net tangible assets (%): 4.120882319835118
Capex to operating income (%): 46.71318911374738
Buffett classification: The Good
Stock price: 14.07363261668709
P/E ratio: 18.064755242652332
Shares outstanding: 833000073
Book value: 4185763618.135235
P/B ratio: 2.800764225261792
Market cap (USD): 11723336997.075527
Debt to equity: 0.18025527203823757
Current ratio: 1.8795338260375214
Quick ratio: 1.3804560672099047
Effective tax rate (%): 22.898438006351675
Interest coverage ratio: 15.180084745762713
COGS to revenue (%): 46.36521978273823
R&D to revenue (%): 7.046110831003347
SG&A to revenue (%): 30.845212449007654
Free cash flow (dilution-adjusted): 39746017.6005347
Buyback yield (%): 0
Retained earnings: 3896435334.7443466
Inventory turnover: 0.5121188725335089
Receivables turnover: 0.7022507624588594
Capitalized R&D asset: 139455325.03372067
ROCI (R&D-adjusted, %): 3.3925898338269005
Rosenberg metric: -0.30504628672859374
FCF margin (%): 4.088554796718155
Revenue growth (%): -2.070592937819692
Rule of 40 score: 2.0179618588984627
Financial ratios for ELEF.TO — annual report dated 2021-12-31
Total revenue: 0
Gross profit: -17371.653543307086
Operating income: -4512570.866141732
Net income: -5377727.559055118
Capital expenditures: 0
Operating cash flow: -1725322.8346456692
Depreciation & amortization: 71021.25984251968
Net tangible assets: 38732511.81102362
Owner earnings: -5306706.299212598
Return on net tangible assets (%): -13.70090926481629
Buffett classification: The Gruesome
Stock price: 2.125984251968504
Shares outstanding: 57537933
Book value: 39913496.850393705
P/B ratio: 3.064746241285855
Market cap (USD): 122324739.4488189
Debt to equity: 0
Current ratio: 0.8884689735930906
Quick ratio: 0.8884689735930906
Free cash flow (dilution-adjusted): -2704693.7007874018
Buyback yield (%): 0
Retained earnings: -151130599.2125984
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.868948020508014
Rule of 40 score: 0
Financial ratios for ELEF.TO — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -111241.91176470587
Operating income: -6137052.94117647
Net income: -5117643.382352941
Capital expenditures: 6943607.352941176
Operating cash flow: -3860212.4999999995
Depreciation & amortization: 111241.91176470587
Net tangible assets: 22151980.147058822
Owner earnings: -11950008.823529411
Return on net tangible assets (%): -53.94555585639619
Buffett classification: The Gruesome
Stock price: 0.29411764705882354
Shares outstanding: 57537933
Book value: 57772347.79411764
P/B ratio: 0.2929242469233927
Market cap (USD): 16922921.470588237
Debt to equity: 0.05160479469664865
Current ratio: 0.4282153510664594
Quick ratio: 0.4282153510664594
Interest coverage ratio: -55.414306391002405
Free cash flow (dilution-adjusted): -12405945.588235293
Buyback yield (%): 0
Retained earnings: -146246952.94117647
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.898182419250974
Rule of 40 score: 0
Financial ratios for ELEF.TO — annual report dated 2024-03-31
Total revenue: 0
Gross profit: -354220.74074074073
Operating income: -9856985.925925925
Net income: -11296236.296296295
Capital expenditures: 375674.8148148148
Operating cash flow: -192652.59259259258
Depreciation & amortization: 366299.2592592592
Net tangible assets: -1873637.7777777778
Owner earnings: -11305611.85185185
Buffett classification: The Gruesome
Stock price: 0.25735294117647056
Shares outstanding: 57537933
Book value: 8036774.814814813
P/B ratio: 1.8424749514530112
Market cap (USD): 14807556.286764704
Debt to equity: 0.3701472840680701
Current ratio: 0.0728657106193283
Quick ratio: 0.0728657106193283
Interest coverage ratio: -4.453652753852327
Free cash flow (dilution-adjusted): -1283027.4074074074
Buyback yield (%): 0
Retained earnings: -185604257.77777776
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -86.51261529115641
Rule of 40 score: 0
Financial ratios for ELEF.TO — quarterly report dated 2024-09-30
Capital expenditures: 221786.66666666666
Buffett classification: The Gruesome
Stock price: 0.4296296296296296
Shares outstanding: 57537933
Market cap (USD): 24720000.844444443
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELEF.TO — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -3595.804195804196
Operating income: -1088501.3986013986
Net income: -1406712.5874125874
Capital expenditures: 782965.034965035
Operating cash flow: 104272.72727272728
Depreciation & amortization: 3595.804195804196
Net tangible assets: 13887951.04895105
Owner earnings: -2186081.8181818184
Return on net tangible assets (%): -15.740851983683598
Buffett classification: The Gruesome
Stock price: 0.13286713286713286
Shares outstanding: 57537933
Book value: 13791716.083916085
P/B ratio: 0.5543110184617764
Market cap (USD): 7644900.188811189
Debt to equity: 0.0006992643906948501
Current ratio: 0.664709684988831
Quick ratio: 0.664709684988831
Free cash flow (dilution-adjusted): -788720.979020979
Buyback yield (%): 0
Retained earnings: -161828146.15384617
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.318968430469548
Rule of 40 score: 0
Financial ratios for ELEF.TO — annual report dated 2025-03-31
Total revenue: 0
Gross profit: -25004.195804195806
Operating income: -2903800.6993006994
Net income: -5754303.496503497
Capital expenditures: 0
Operating cash flow: -2516369.230769231
Depreciation & amortization: 25004.195804195806
Net tangible assets: -6722247.552447553
Owner earnings: -5729299.300699301
Buffett classification: The Gruesome
Stock price: 0.13986013986013987
Shares outstanding: 57537933
Book value: -6914652.447552448
Market cap (USD): 8047263.356643357
Debt to equity: -0.0055226799722854665
Current ratio: 0.012561171452597109
Quick ratio: 0.012561171452597109
Interest coverage ratio: -1.535339615783797
Free cash flow (dilution-adjusted): -3005539.8601398603
Buyback yield (%): 0
Retained earnings: -180975106.2937063
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELEF.TO — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -3485.3146853146854
Operating income: -843390.2097902098
Net income: -2607217.4825174827
Capital expenditures: 782965.034965035
Operating cash flow: -1273036.3636363638
Depreciation & amortization: 3485.3146853146854
Net tangible assets: -6722247.552447553
Owner earnings: -3386697.202797203
Buffett classification: The Gruesome
Stock price: 0.13986013986013987
Shares outstanding: 57537933
Book value: -6914652.447552448
Market cap (USD): 8047263.356643357
Debt to equity: -0.0055226799722854665
Current ratio: 0.012561171452597109
Quick ratio: 0.012561171452597109
Interest coverage ratio: -0.4595088251901399
Free cash flow (dilution-adjusted): -612320.979020979
Buyback yield (%): 0
Retained earnings: -180975106.2937063
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELEF.TO — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -3408.759124087591
Operating income: -572326.2773722627
Net income: -1453334.306569343
Capital expenditures: 428732.1167883211
Operating cash flow: -263527.0072992701
Depreciation & amortization: 3408.759124087591
Net tangible assets: -6779147.445255474
Owner earnings: -1878657.6642335765
Buffett classification: The Gruesome
Stock price: 0.1678832116788321
Shares outstanding: 57537933
Book value: -7049408.759124085
Market cap (USD): 9659652.985401459
Debt to equity: -0.005206317452724204
Current ratio: 0.016430535242496314
Quick ratio: 0.016430535242496314
Interest coverage ratio: -1.2586999585830922
Free cash flow (dilution-adjusted): -775936.4963503649
Buyback yield (%): 0
Retained earnings: -190354357.66423357
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELEF.TO — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -3359.7122302158277
Operating income: -565583.4532374102
Net income: -1257907.9136690649
Capital expenditures: 0
Operating cash flow: -330459.71223021584
Depreciation & amortization: 3359.7122302158277
Net tangible assets: -7394725.899280576
Owner earnings: -1254548.201438849
Buffett classification: The Gruesome
Stock price: 0.1510791366906475
Shares outstanding: 57537933
Book value: -7394725.899280578
Market cap (USD): 8692781.244604317
Debt to equity: -0.004464585833049006
Current ratio: 0.009779690566050254
Quick ratio: 0.009779690566050254
Interest coverage ratio: -1.259263945974865
Free cash flow (dilution-adjusted): 23535.25179856115
Buyback yield (%): 0
Retained earnings: -188873353.95683455
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELEF.TO — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -3408.029197080292
Operating income: 4212916.05839416
Net income: 19184491.24087591
Capital expenditures: 0
Operating cash flow: 105849.63503649634
Depreciation & amortization: 3408.029197080292
Net tangible assets: 12062462.773722626
Owner earnings: 19187899.270072993
Return on net tangible assets (%): 159.07115843600957
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.2408759124087591
P/E ratio: 0.9995291061748259
Shares outstanding: 57537933
Book value: 12062462.773722626
P/B ratio: 1.148977814023283
Market cap (USD): 13859502.10948905
Debt to equity: 0.002507386430268625
Current ratio: 0.0633167485741617
Quick ratio: 0.0633167485741617
Free cash flow (dilution-adjusted): -1510229.9270072991
Buyback yield (%): 0
Retained earnings: -172446137.95620435
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.846482353043086
Rule of 40 score: 0
Financial ratios for ETERNAL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.085322431755242
Shares outstanding: 9205393097
Market cap (USD): 9990819621.298958
Buyback yield (%): 0
Retained earnings: -887326915.4688119
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ETERNAL.NS — annual report dated 2023-03-31
Total revenue: 856881851.4007308
Gross profit: 686967113.2764921
Operating income: -193057247.2594397
Net income: -118270401.94884288
Capital expenditures: 12302070.645554204
Operating cash flow: -102801461.63215591
Depreciation & amortization: 53227771.01096225
Net tangible assets: 1675152253.3495739
Owner earnings: -77344701.58343484
Return on net tangible assets (%): -4.617174434668799
Buffett classification: The Gruesome
Stock price: 0.6211936662606578
Shares outstanding: 9205393097
Book value: 2369427527.4056034
P/B ratio: 2.4133812159923913
Market cap (USD): 5718331887.29598
Debt to equity: 0.026062818074333003
Current ratio: 7.516308119361555
Quick ratio: 7.458709229701596
Interest coverage ratio: -34.45652173913043
COGS to revenue (%): 19.829424307036252
SG&A to revenue (%): 23.11300639658849
Free cash flow (dilution-adjusted): -176979293.544458
Buyback yield (%): 0
Retained earnings: -914616321.5590744
Inventory turnover: 16.80722891566265
Receivables turnover: 15.393873085339168
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.862883222541918
FCF margin (%): -20.653873489694387
Rule of 40 score: -20.653873489694387
Financial ratios for ETERNAL.NS — annual report dated 2024-03-31
Total revenue: 1452692169.3248591
Gross profit: 1107087180.7171123
Operating income: -42331214.77395371
Net income: 42091377.86305312
Capital expenditures: 24223528.000959348
Operating cash flow: 77467322.22088979
Depreciation & amortization: 63077107.56685454
Net tangible assets: 1791941479.7937403
Owner earnings: 80944957.4289483
Return on net tangible assets (%): 4.517165227865889
Buffett classification: The Gruesome
Stock price: 2.1845009596928984
P/E ratio: 477.75081443457054
Shares outstanding: 9205393097
Book value: 2447056001.9186954
P/B ratio: 8.217707334437627
Market cap (USD): 20109190054.746883
Debt to equity: 0.03670489071841615
Current ratio: 2.6202592414786365
Quick ratio: 2.5780124819971197
Effective tax rate (%): -20.61855670103093
Interest coverage ratio: -5.115942028985508
COGS to revenue (%): 23.79065543998679
SG&A to revenue (%): 15.88245005778438
Free cash flow (dilution-adjusted): -10073150.257824682
Buyback yield (%): 0
Retained earnings: -722388775.6325698
Inventory turnover: 32.75
Receivables turnover: 15.25692695214106
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6593804352935646
FCF margin (%): -0.6934125804853889
Revenue growth (%): 69.53237683236806
Rule of 40 score: 68.83896425188267
Financial ratios for ETERNAL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1733755375.059723
Buffett classification: The Gruesome
Stock price: 3.264452938365982
Shares outstanding: 9205393097
Book value: 2545508838.9870996
P/B ratio: 11.805330267984141
Market cap (USD): 30050572544.31558
Debt to equity: 0.054385059359016476
Current ratio: 2.01500938086304
Quick ratio: 1.9624765478424018
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ETERNAL.NS — quarterly report dated 2024-12-31
Total revenue: 630026809.6514745
Gross profit: 455181256.5567082
Operating income: -9907914.67537009
Net income: 6877258.421727474
Capital expenditures: 0
Depreciation & amortization: 28791234.409604847
Owner earnings: 35668492.83133232
Buffett classification: The Gruesome
Stock price: 3.241053735866651
P/E ratio: 1084.5591316190043
Shares outstanding: 9205393097
Market cap (USD): 29835173687.15293
Effective tax rate (%): 52.41935483870967
Interest coverage ratio: -1.9767441860465118
COGS to revenue (%): 27.75208140610546
SG&A to revenue (%): 9.639222941720629
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ETERNAL.NS — quarterly report dated 2025-03-31
Total revenue: 681903203.1797988
Gross profit: 491115267.71101236
Operating income: -25134440.028057046
Net income: 4559270.516717325
Capital expenditures: 0
Depreciation & amortization: 33551554.82815057
Net tangible assets: 2766892681.7862988
Owner earnings: 38110825.34486789
Return on net tangible assets (%): 1.3773871894541152
Buffett classification: The Gruesome
Stock price: 2.3538335861827515
P/E ratio: 1188.1266622743844
Shares outstanding: 9205393097
Book value: 3543371522.094926
P/B ratio: 6.115069591382514
Market cap (USD): 21667963445.733456
Debt to equity: 0.06746948201913561
Current ratio: 3.5180396873120863
Quick ratio: 3.4651232711966324
Effective tax rate (%): 59.79381443298969
Interest coverage ratio: -3.839285714285714
COGS to revenue (%): 27.97874164237956
SG&A to revenue (%): 10.869192525287161
Buyback yield (%): 0
Retained earnings: -615501519.7568389
Inventory turnover: 9.272727272727272
Receivables turnover: 2.9974306269270294
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6656965043192866
Revenue growth (%): 8.233997781304252
Rule of 40 score: 8.233997781304252
Financial ratios for ETERNAL.NS — annual report dated 2025-03-31
Total revenue: 2366495206.9207387
Gross profit: 1715922375.4968433
Operating income: -26420388.12251578
Net income: 61608604.161795646
Capital expenditures: 108837970.54009819
Operating cash flow: 36006546.64484452
Depreciation & amortization: 100888473.22889875
Net tangible assets: 2766892681.7862988
Owner earnings: 53659106.85059619
Return on net tangible assets (%): 1.9393273618387687
Buffett classification: The Gruesome
Stock price: 2.3538335861827515
P/E ratio: 351.70352811158256
Shares outstanding: 9205393097
Book value: 3543371522.094926
P/B ratio: 6.115069591382514
Market cap (USD): 21667963445.733456
Debt to equity: 0.06746948201913561
Current ratio: 3.5180396873120863
Quick ratio: 3.4651232711966324
Effective tax rate (%): 24.39024390243903
Interest coverage ratio: -1.4675324675324675
COGS to revenue (%): 27.490984537864943
SG&A to revenue (%): 9.74163908511584
Free cash flow (dilution-adjusted): -166705634.79074118
Buyback yield (%): 0
Retained earnings: -615501519.7568389
Inventory turnover: 31.61931818181818
Receivables turnover: 10.402363823227132
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6997553952379477
FCF margin (%): -7.044410413476264
Revenue growth (%): 62.90410707043124
Rule of 40 score: 55.85969665695497
Financial ratios for ETERNAL.NS — quarterly report dated 2025-06-30
Total revenue: 838637959.279195
Gross profit: 571378422.6538732
Operating income: -23285747.718230754
Net income: 2925345.1907325066
Capital expenditures: 0
Depreciation & amortization: 36742335.595600285
Owner earnings: 39667680.78633279
Buffett classification: The Gruesome
Stock price: 3.0909197285279664
P/E ratio: 1981.1572554147112
Shares outstanding: 9205393097
Market cap (USD): 28453131132.372456
Effective tax rate (%): 71.5909090909091
Interest coverage ratio: -2.970149253731343
COGS to revenue (%): 31.868285196037395
SG&A to revenue (%): 9.362355239291196
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 22.98489805716157
Rule of 40 score: 22.98489805716157
Financial ratios for ETERNAL.NS — quarterly report dated 2025-12-31
Total revenue: 1817422301.4370058
Gross profit: 725632171.1039323
Operating income: -7909101.03598084
Net income: 11362370.50239501
Capital expenditures: 0
Depreciation & amortization: 48902751.47599421
Owner earnings: 60265121.97838922
Buffett classification: The Gruesome
Stock price: 3.097359919795032
P/E ratio: 1108.3868946577861
Shares outstanding: 9205393097
Market cap (USD): 28512415624.605663
Effective tax rate (%): 40
Interest coverage ratio: -0.663551401869159
COGS to revenue (%): 60.0735519460619
SG&A to revenue (%): 5.7431811216671775
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 116.7111900108923
Rule of 40 score: 116.7111900108923
Financial ratios for EXM.BR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.6818181818181819
Shares outstanding: 79516197
Market cap (USD): 133731785.86363637
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EXM.BR — annual report dated 2022-12-31
Total revenue: 165537234.0425532
Gross profit: 32894680.851063833
Operating income: -12379787.234042553
Net income: 340795744.6808511
Capital expenditures: 7126595.744680852
Operating cash flow: 27643617.021276597
Depreciation & amortization: 35770212.76595745
Net tangible assets: 849240425.531915
Owner earnings: 369439361.7021277
Return on net tangible assets (%): 43.502328739324
Buffett classification: The Gruesome
Stock price: 2.351063829787234
P/E ratio: 0.5485621741668435
Shares outstanding: 79516197
Book value: 849671276.5957446
P/B ratio: 0.22002350767693638
Market cap (USD): 186947654.64893615
Debt to equity: 0.2733823218240847
Current ratio: 4.679147157837712
Quick ratio: 4.612158031188329
Effective tax rate (%): 0.3335200049779105
Interest coverage ratio: -0.530062858704564
COGS to revenue (%): 80.12853057421034
SG&A to revenue (%): 23.42469714983452
Free cash flow (dilution-adjusted): 5864893.617021277
Buyback yield (%): 0
Retained earnings: 577314893.6170213
Inventory turnover: 14.404343807763402
Receivables turnover: 3.304627604221972
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1092777255088122
FCF margin (%): 3.54294527810803
Rule of 40 score: 3.54294527810803
Financial ratios for EXM.BR — annual report dated 2023-12-31
Total revenue: 541464444.4444444
Gross profit: 113776666.66666666
Operating income: 50726666.666666664
Net income: 80007777.77777778
Capital expenditures: 6768888.888888889
Operating cash flow: 57620000
Depreciation & amortization: 37728888.88888889
Net tangible assets: 535197777.7777778
Owner earnings: 110967777.77777776
Return on net tangible assets (%): 20.73397580956572
Capex to operating income (%): 13.343847198493014
Buffett classification: The Great
Stock price: 6.855555555555555
P/E ratio: 6.813433909064396
Shares outstanding: 79516197
Book value: 535710000.00000006
P/B ratio: 1.0175798586922027
Market cap (USD): 545127706.1
Debt to equity: 0.5502811429898846
Current ratio: 1.5694016291366393
Quick ratio: 1.5014954167772494
Effective tax rate (%): 5.446714638373865
Interest coverage ratio: 4.33273227673911
COGS to revenue (%): 78.98723215641532
SG&A to revenue (%): 5.83848739426822
Free cash flow (dilution-adjusted): 50417777.777777776
Buyback yield (%): 0
Retained earnings: 314167777.7777778
Inventory turnover: 28.930402104472005
Receivables turnover: 9.797305991154001
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.245408693011363
FCF margin (%): 9.311373682072075
Revenue growth (%): 227.0952590069585
Rule of 40 score: 236.4066326890306
Financial ratios for EXM.BR — annual report dated 2024-12-31
Total revenue: 363448958.3333334
Gross profit: 109756250
Operating income: 73300000
Net income: 188532291.6666667
Capital expenditures: 7091666.666666667
Operating cash flow: 54535416.66666667
Depreciation & amortization: 33022916.666666668
Net tangible assets: 634864583.3333334
Owner earnings: 214463541.6666667
Return on net tangible assets (%): 33.780990040527016
Capex to operating income (%): 9.674852205547976
Buffett classification: The Great
Stock price: 7.750000000000001
P/E ratio: 3.2686736118370527
Shares outstanding: 79516197
Book value: 635027083.3333333
P/B ratio: 0.9704318806612581
Market cap (USD): 616250526.7500001
Debt to equity: 0.5192560684747699
Current ratio: 3.7563973728600653
Quick ratio: 3.7563973728600653
Effective tax rate (%): 5.787339479149857
Interest coverage ratio: 4.095210382354653
COGS to revenue (%): 69.80146799613655
SG&A to revenue (%): 10.774380859302228
Free cash flow (dilution-adjusted): 42527083.333333336
Buyback yield (%): 0
Retained earnings: 457282291.6666667
Receivables turnover: 3.689759099849834
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.743520105993613
FCF margin (%): 11.7009781864143
Revenue growth (%): -32.87667139321756
Rule of 40 score: -21.175693206803263
Financial ratios for EXM.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 634864583.3333334
Buffett classification: The Gruesome
Stock price: 7.750000000000001
Shares outstanding: 79516197
Book value: 635027083.3333333
P/B ratio: 0.9704318806612581
Market cap (USD): 616250526.7500001
Debt to equity: 0.5192560684747699
Current ratio: 3.7563973728600653
Quick ratio: 3.7563973728600653
Buyback yield (%): 0
Retained earnings: 457282291.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EXM.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 775857647.0588236
Buffett classification: The Gruesome
Stock price: 8.941176470588236
Shares outstanding: 79516197
Book value: 776040000
P/B ratio: 0.9161491026842159
Market cap (USD): 710968349.6470588
Debt to equity: 0.45435195881352386
Current ratio: 4.356676041114125
Quick ratio: 4.356676041114125
Buyback yield (%): 0
Retained earnings: 52214117.64705882
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FABTECH.NS — quarterly report dated 2025-12-31
Total revenue: 6991188.593071182
Gross profit: 2431725.520775315
Operating income: -1422223.4599532138
Net income: -632494.1517210649
Capital expenditures: 0
Depreciation & amortization: 146073.29842931937
Owner earnings: -486420.85329174553
Buffett classification: The Gruesome
Stock price: 2.1912665701236493
Shares outstanding: 44450794
Market cap (USD): 97403538.90765288
Interest coverage ratio: -14.609566311935005
COGS to revenue (%): 65.21728046093128
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -55.6553435372498
Rule of 40 score: -55.6553435372498
Financial ratios for FMR.AX — annual report dated 2021-06-30
Total revenue: 1923725.5639097744
Gross profit: 1923725.5639097744
Operating income: -1996672.1804511277
Net income: -2106114.2857142854
Capital expenditures: 4120.300751879699
Depreciation & amortization: 316658.6466165413
Net tangible assets: 1081479.6992481202
Owner earnings: -1793575.939849624
Return on net tangible assets (%): -165.8446239070947
Buffett classification: The Gruesome
Stock price: 0.07518796992481203
Shares outstanding: 63948767
Book value: 1550375.1879699246
P/B ratio: 3.101299612657426
Market cap (USD): 4808177.969924812
Debt to equity: 0.1324244095171724
Current ratio: 1.7699398935849122
Quick ratio: 1.7699398935849122
COGS to revenue (%): 0
R&D to revenue (%): 2.4538460185534414
SG&A to revenue (%): 156.73671271479407
Free cash flow (dilution-adjusted): -2214422.5563909775
Buyback yield (%): 0.06011061949013028
Retained earnings: -16957578.19548872
Receivables turnover: 24.099343487147607
Capitalized R&D asset: 47205.26315789473
ROCI (R&D-adjusted, %): -112.38363952643584
FCF margin (%): -115.11114672148928
Rule of 40 score: -115.11114672148928
Financial ratios for FMR.AX — annual report dated 2022-06-30
Total revenue: 1437006.8965517243
Gross profit: 1437006.8965517243
Operating income: -1886398.6206896552
Net income: -1882279.3103448276
Capital expenditures: 17822.758620689656
Depreciation & amortization: 409922.7586206897
Net tangible assets: 3087961.379310345
Owner earnings: -1490179.3103448276
Return on net tangible assets (%): -48.25770556358575
Buffett classification: The Gruesome
Stock price: 0.020689655172413793
Shares outstanding: 63948767
Book value: 3458782.7586206896
P/B ratio: 0.38252704210271304
Market cap (USD): 1323077.9379310345
Debt to equity: 0
Current ratio: 4.417168341433389
Quick ratio: 4.417168341433389
Interest coverage ratio: -281.92929292929296
COGS to revenue (%): 0
R&D to revenue (%): 0.9852375147576858
SG&A to revenue (%): 175.70203392108118
Free cash flow (dilution-adjusted): -1209243.448275862
Buyback yield (%): 22.001883685002614
Retained earnings: -17436471.724137932
Receivables turnover: 29.285453267744202
Capitalized R&D asset: 45785.457350272234
ROCI (R&D-adjusted, %): -53.2757880540358
Rosenberg metric: -10.310686453119581
FCF margin (%): -84.15014925659655
Revenue growth (%): -25.300836901540386
Rule of 40 score: -109.45098615813694
Financial ratios for FMR.AX — annual report dated 2023-06-30
Total revenue: 1359011.2582781457
Gross profit: 1359011.2582781457
Operating income: -1967249.6688741723
Net income: -2124522.5165562914
Capital expenditures: 14188.079470198676
Depreciation & amortization: 166903.31125827815
Net tangible assets: 1221800.6622516557
Owner earnings: -1971807.284768212
Return on net tangible assets (%): -161.38535079317845
Buffett classification: The Gruesome
Stock price: 0.006622516556291391
Shares outstanding: 63948767
Book value: 1221800.6622516557
P/B ratio: 0.34662100070518
Market cap (USD): 423501.7682119205
Debt to equity: 0
Current ratio: 2.1191155264714947
Quick ratio: 2.1191155264714947
Interest coverage ratio: -1524.9214579055442
COGS to revenue (%): 0
R&D to revenue (%): 0.8987835429634031
SG&A to revenue (%): 230.3284867699394
Free cash flow (dilution-adjusted): -1466836.4238410597
Buyback yield (%): 0
Retained earnings: -18868154.304635763
Receivables turnover: 23.644509736144716
Capitalized R&D asset: 37278.12017163256
ROCI (R&D-adjusted, %): -150.83686645169746
Rosenberg metric: -5.508971479209361
FCF margin (%): -107.93408920684935
Revenue growth (%): -5.4276453690472035
Rule of 40 score: -113.36173457589655
Financial ratios for FMR.AX — annual report dated 2024-06-30
Operating income: -845011.3333333334
Net income: -358842
Capital expenditures: 1199.3333333333333
Net tangible assets: 3226923.3333333335
Owner earnings: -360041.3333333333
Return on net tangible assets (%): -11.157418263216664
Buffett classification: The Gruesome
Stock price: 0.26666666666666666
Shares outstanding: 63948767
Book value: 3226923.3333333335
P/B ratio: 5.284601700071379
Market cap (USD): 17053004.53333333
Debt to equity: 0
Current ratio: 7.870513122175123
Quick ratio: 7.870513122175123
Interest coverage ratio: -211252.83333333334
Free cash flow (dilution-adjusted): -1068953.3333333333
Buyback yield (%): 0.1320001994721806
Retained earnings: -19352784
Capitalized R&D asset: 12855.878830783286
ROCI (R&D-adjusted, %): -26.353714588058107
Rule of 40 score: 0
Financial ratios for FOUR.L — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 6775675.675675676
Buffett classification: The Gruesome
Stock price: 0.292027027027027
Shares outstanding: 28045027
Market cap (USD): 8189905.857702701
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0